Compare IINN & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IINN | YI |
|---|---|---|
| Founded | 2018 | 2010 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.3M | 38.1M |
| IPO Year | 2021 | N/A |
| Metric | IINN | YI |
|---|---|---|
| Price | $0.94 | $2.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 174.4K | 16.8K |
| Earning Date | 10-01-2025 | 12-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $289,000.00 | ★ $1,908,028,152.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,582.74 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.40 | $2.48 |
| 52 Week High | $1.65 | $11.35 |
| Indicator | IINN | YI |
|---|---|---|
| Relative Strength Index (RSI) | 42.63 | 36.83 |
| Support Level | $0.92 | $2.60 |
| Resistance Level | $1.12 | $3.00 |
| Average True Range (ATR) | 0.06 | 0.25 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 25.04 | 28.17 |
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.